Breast Cancer Clinical Trials in Baltimore

Showing 501-520 of 691 trials

MRI to Detect Breast Tumors in Women

NCT00003302

RATIONALE: New imaging procedures, such as MRI, may improve the ability to detect breast tumors. PURPOSE: Diagnostic study to determine the value of MRI in detecting breast tumors in women who have had suspicious mammographic or clinical examinations.

Breast Cancer

Abramson Cancer Center at Penn Medicine1,500 participantsStarted May 1998

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +12 more locations

COMPLETEDNA< 1 mile

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

NCT00058058

RATIONALE: Diagnostic procedures such as magnetic resonance imaging (MRI) may improve the ability to detect cancer in the unaffected breast of women recently diagnosed with unilateral breast cancer. PURPOSE: Diagnostic trial to determine the effectiveness of MRI in evaluating the unaffected breast of women recently diagnosed with unilateral breast cancer.

Breast CancerContralateral Breast Cancer

American College of Radiology Imaging Network1,007 participantsStarted Feb 2003

Little Rock, Arkansas, United States • Los Angeles, California, United States • San Francisco, California, United States +18 more locations

MRI to Detect Breast Tumors in Women

Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer

Breast Cancer Trials in Other Cities

Neoadjuvant Docetaxel in Treating Women With Newly Diagnosed Breast Cancer

Evaluate Risk/Benefit of Nab Paclitaxel in Combination With Gemcitabine and Carboplatin Compared to Gemcitabine and Carboplatin in Triple Negative Metastatic Breast Cancer (or Metastatic Triple Negative Breast Cancer)

A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi

Study To Evaluate the Efficacy and Safety Of Bevacizumab, and Associated Biomarkers, In Combination With Paclitaxel Compared With Paclitaxel Plus Placebo as First-line Treatment Of Patients With Her2-Negative Metastatic Breast Cancer

CYP17 Lyase and Androgen Receptor Inhibitor Treatment With Seviteronel Trial (INO-VT-464-006; NCT02580448)

Combination Chemotherapy and Paclitaxel Plus Trastuzumab in Treating Women With Palpable Breast Cancer That Can Be Removed by Surgery

PANVAC-V and PANVAC-F Vaccines Plus Sargramostim to Treat Advanced Cancer

MRI for Detecting Cancer in Women Who Are at High Risk of Developing Breast Cancer

Nueva Vida Intervention for Latina Breast Cancer Survivors and Caregivers

A Study of Abemaciclib (LY2835219) in Participants With HR+, HER2- Advanced Breast Cancer

Prasterone (Dehydroepiandrosterone) in Treating Postmenopausal Cancer Survivors With Vaginal Symptoms

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography (ADAPT)

Safety Study of Enzalutamide (MDV3100) in Patients With Incurable Breast Cancer

A Study of Abiraterone Acetate Plus Prednisone With or Without Exemestane in Postmenopausal Women With Estrogen Receptor-Positive (ER+) Metastatic Breast Cancer Progressing After Letrozole or Anastrozole Therapy

Fresolimumab and Radiotherapy in Metastatic Breast Cancer

AirXpanders AeroForm Tissue Expander System for Breast Reconstruction

Assessment of Diagnostic Accuracy and Performance of Digital Breast Tomosynthesis Compared to Mammography

Open Label, Multi-center Study to Assess the Safety, Tolerability and Pharmacokinetics of CUDC-907 in Subjects With Advanced/Relapsed Solid Tumors

Other Conditions in Baltimore